Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 26:13:891622.
doi: 10.3389/fneur.2022.891622. eCollection 2022.

Hypo-high density lipoproteinemia is a predictor for recurrent stroke during the long-term follow-up after revascularization in adult moyamoya disease

Xiaofan Yu  1 , Peicong Ge  1 , Yuanren Zhai  1 , Rong Wang  1   2   3 , Yan Zhang  1   2   3 , Dong Zhang  1   2   3
Affiliations

Hypo-high density lipoproteinemia is a predictor for recurrent stroke during the long-term follow-up after revascularization in adult moyamoya disease

Xiaofan Yu et al. Front Neurol. .

Abstract

Objective: Previous studies have reported that hypo-high-density lipoproteinemia (HHDL) was an independent risk factor for the cerebrovascular event. However, the risk of HHDL for stroke recurrence in moyamoya disease (MMD) during long-term follow-up after revascularization remains poorly understood. We aim to investigate the association between HHDL and stroke recurrence in adult patients with MMD.

Methods: A total of 138 adult patients with MMD were prospectively recruited from 1 July to 31 December 2019. After excluding 15 patients who did not meet the inclusion criteria, all the 123 patients were enrolled. Participants were grouped according to the stroke recurrence and HHDL presentation, respectively. Clinical data and laboratory examinations were compared by the statistical analysis. The Kaplan-Meier survival analysis was conducted to compare the stroke-free survival rates between participants with HHDL and those without. Univariate and multivariate logistic regression analyses were performed to identify independent factors of the neurological status. Univariate and multivariate Cox regression analyses were conducted to identify the predictors for the recurrent stroke.

Results: Participants with recurrent stroke group showed a lower level of high-density lipoprotein (HDL) (p = 0.030). More participants in the recurrent stroke group had HHDL (p = 0.045). What is more, there was statistical significance in the Kaplan-Meier curve of stroke incidence between the normal HDL group and the HHDL group (log-rank test, p = 0.034). Univariate logistic analysis results showed that HHDL (OR 0.916, 95% CI 0.237-3.543; p = 0.899) and HDL (OR 0.729, 95% CI 0.094-5.648; p = 0.763) were not predictive factors for the neurological status. In the multivariate Cox regression analysis, diabetes (HR 4.195, 95% CI 1.041-16.899; p = 0.044), HDL (HR 0.061, 95% CI 0.006-0.626; p = 0.019), and HHDL (HR 3.341, 95% CI 1.110-10.051; p = 0.032) were independent risk factors for the recurrent stroke.

Conclusions: Hypo-high-density lipoproteinemia might be a predictor or the potential therapeutic target for recurrent stroke during the long-term follow-up after revascularization in adult patients with MMD.

Keywords: follow-up; high density lipoprotein; hypo-high density lipoproteinemia; moyamoya disease; stroke recurrence.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The Kaplan–Meier cumulative hazard curve for stroke recurrence comparing participants with HHDL and participants without HHDL.
Figure 2
Figure 2
The Kaplan–Meier cumulative hazard curve for stroke recurrence comparing participants with diabetes and participants without diabetes.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. (2009) 360:1226–37. 10.1056/NEJMra0804622 - DOI - PubMed
    1. Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. (1969) 20:288–99. 10.1001/archneur.1969.00480090076012 - DOI - PubMed
    1. Kim T, Oh CW, Bang JS, Kim JE, Cho WS. Moyamoya disease: treatment and outcomes. J Stroke. (2016) 18:21–30. 10.5853/jos.2015.01739 - DOI - PMC - PubMed
    1. Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, et al. . Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke. (2008) 39:42–7. 10.1161/STROKEAHA.107.490714 - DOI - PubMed
    1. Chen Y, Ma L, Lu J, Chen X, Ye X, Zhang D, et al. . Postoperative hemorrhage during the acute phase after direct or combined revascularization for moyamoya disease: risk factors, prognosis, and literature review. J Neurosurg. (2019) 133:1–10. 10.3171/2019.7.JNS19885 - DOI - PubMed

LinkOut - more resources